{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:20:01Z","timestamp":1755224401842,"version":"3.43.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.soc.2024.08.003","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T09:12:32Z","timestamp":1729761152000},"page":"83-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Posttreatment Surveillance of Anal Cancer"],"prefix":"10.1016","volume":"34","author":[{"given":"Jai","family":"Bikhchandani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.soc.2024.08.003_bib1","first-page":"12","article-title":"Cancer statistics 2023","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.soc.2024.08.003_bib3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jnci\/djz219","article-title":"Recent trends in squamous cell cancer of the anus: incidence and mortality in the US 2001-2015","volume":"112","author":"Deshmukh","year":"2020","journal-title":"J\u00a0Natl Cancer Inst"},{"year":"2022","series-title":"Cancer facts & figures 2022","key":"10.1016\/j.soc.2024.08.003_bib4"},{"issue":"16","key":"10.1016\/j.soc.2024.08.003_bib5","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin and radiotherapy versus fluorouracil, cisplatin and radiotherapy for carcinoma of anal canal: a randomized controlled trial","volume":"299","author":"Ajam","year":"2008","journal-title":"JAMA"},{"issue":"9034","key":"10.1016\/j.soc.2024.08.003_bib6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fuorouracil, and mitomycin. UKCCCR anal cancer trial working party. UK Co-ordinating committee on cancer research","volume":"348","year":"1996","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.soc.2024.08.003_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.soc.2016.07.006","article-title":"Locally recurrent disease related to anal canal cancers","volume":"26","author":"Sammour","year":"2017","journal-title":"Surg Oncol Clin N Am"},{"issue":"7","key":"10.1016\/j.soc.2024.08.003_bib8","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomized UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.soc.2024.08.003_bib9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomized, phase 3, open-label, 2 x 2 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.soc.2024.08.003_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/annonc\/mdu159","article-title":"Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Glynne-Jones","year":"2014","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.soc.2024.08.003_bib12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/DCR.0000000000001114","article-title":"The American society of colon and rectal surgeons clinical practice guidelines for anal squamous cell cancers)","volume":"61","author":"Stewart","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"10.1016\/j.soc.2024.08.003_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1470-2045(17)30071-2","article-title":"Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomized controlled phase 3 trial","volume":"18","author":"Glynne-Jones","year":"2017","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.soc.2024.08.003_bib14","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1245\/s10434-007-9491-8","article-title":"Outcomes of salvage surgery for squamous cell carcinoma of the anal canal","volume":"14","author":"Schiller","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.soc.2024.08.003_bib15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/codi.13288","article-title":"Survival following salvage abdominoperineal resection for persistent and recurrent squamous cell carcinoma of the anus; do these disease categories affect survival?","volume":"18","author":"Severino","year":"2016","journal-title":"Colorectal Dis"},{"issue":"6","key":"10.1016\/j.soc.2024.08.003_bib16","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/codi.14569","article-title":"A\u00a0systematic review of outcomes after salvage abdominoperineal resection for persistent or recurrent anal squamous cell cancer","volume":"21","author":"Ko","year":"2019","journal-title":"Colorectal Dis"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320724000644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320724000644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T15:17:36Z","timestamp":1755011856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320724000644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1055320724000644"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2024.08.003","relation":{},"ISSN":["1055-3207"],"issn-type":[{"type":"print","value":"1055-3207"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Posttreatment Surveillance of Anal Cancer","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2024.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}